Cargando…

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges

Opioid misuse and opioid-involved overdose deaths are a massive public health problem involving the intertwined misuse of prescription opioids for pain management with the emergence of extremely potent fentanyl derivatives, sold as standalone products or adulterants in counterfeit prescription opioi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salinsky, Leah M., Merritt, Christina R., Zamora, Joshua C., Giacomini, Juliana L., Anastasio, Noelle C., Cunningham, Kathryn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598667/ https://www.ncbi.nlm.nih.gov/pubmed/37886127 http://dx.doi.org/10.3389/fphar.2023.1239159

Ejemplares similares

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives
por: Roseman, Leor, et al.
Publicado: (2022)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

Heightened cocaine-seeking in male rats associates with a distinct transcriptomic profile in the medial prefrontal cortex
por: Merritt, Christina R., et al.
Publicado: (2022)

Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist
por: Ye, Liang, et al.
Publicado: (2023)

Ghrelin receptor antagonist JMV2959 blunts cocaine and oxycodone drug-seeking, but not self-administration, in male rats
por: Merritt, Christina R., et al.
Publicado: (2023)

Bedside to bench: the outlook for psychedelic research
por: Acero, Victor P., et al.
Publicado: (2023)

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
por: Kettner, H., et al.
Publicado: (2021)

Serotonin 5-HT(2C) Receptor Activation Suppresses Binge Intake and the Reinforcing and Motivational Properties of High-Fat Food
por: Price, Amanda E., et al.
Publicado: (2018)

Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats
por: Price, Amanda E., et al.
Publicado: (2018)

Predicting Responses to Psychedelics: A Prospective Study
por: Haijen, Eline C. H. M., et al.
Publicado: (2018)

Unifying Theories of Psychedelic Drug Effects
por: Swanson, Link R.
Publicado: (2018)

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
por: Levy-Cooperman, N., et al.
Publicado: (2016)

Amazonian Medicine and the Psychedelic Revival: Considering the “Dieta”
por: O’Shaughnessy, David M., et al.
Publicado: (2021)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Editorial: Computational and Experimental Approaches in Multi-target Pharmacology
por: Anastasio, Thomas J.
Publicado: (2017)

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
por: Schindler, Emmanuelle A. D., et al.
Publicado: (2018)

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity
por: Wiskerke, Joost, et al.
Publicado: (2012)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
por: Markopoulos, Athanasios, et al.
Publicado: (2022)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
por: Lattanzi, Roberta, et al.
Publicado: (2018)

In Vivo and In Vitro Analyses of Novel Peptidomimetic Disruptors for the Serotonin 5-HT(2C) Receptor Interaction With Phosphatase and Tensin Homolog
por: Soto, Claudia A., et al.
Publicado: (2019)

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities
por: Yaden, David B, et al.
Publicado: (2021)

Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
por: Edinoff, Amber N., et al.
Publicado: (2021)

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
por: Chen, Chongguang, et al.
Publicado: (2022)

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022)

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
por: Schenberg, Eduardo Ekman
Publicado: (2018)

Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs
por: Tagliazucchi, Enzo
Publicado: (2022)

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
por: Vorobyeva, Nataliya, et al.
Publicado: (2022)

Pharmacological Profiles of Oligomerized μ-Opioid Receptors
por: Lee, Cynthia Wei-Sheng, et al.
Publicado: (2013)

Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor
por: Ben Haddou, Tanila, et al.
Publicado: (2014)

Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2017)

Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers
por: Khani, Samira, et al.
Publicado: (2023)

Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis
por: Basedow, Lukas A., et al.
Publicado: (2021)

Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders
por: Vorobyeva, Nataliya, et al.
Publicado: (2023)

Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology
por: Pichini, Simona, et al.
Publicado: (2019)

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
por: Szabo, Attila
Publicado: (2015)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor
por: Cong, Xiaojing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gnfkqb5bhc35ag0jpvdu88pj4v